A Phase 1 Open-Label, Non-Randomized, Single-Dose, Pharmacokinetic Study Evaluating Staccato Alprazolam 1 mg Inhaler in Smoker Versus Non-Smoker Healthy Adult Volunteers
Latest Information Update: 30 Mar 2021
At a glance
- Drugs Alprazolam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Engage Therapeutics
Most Recent Events
- 10 Dec 2019 Results assessing Pharmacokinetic and Safety of Alprazolam 1 mg Inhaler in Smoker versus Non-Smoker Healthy Adult Participant,presented at the 73rd Annual Meeting of the American Epilepsy Society
- 04 Dec 2019 According to an Engage Therapeutics media release, data from this study will be presented at the American Epilepsy Society Annual Meeting (AES 2019), which is being held Dec. 6-10, at the Baltimore Convention Center.
- 14 Dec 2018 Status changed from recruiting to completed.